Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) BriefCommunication Pages: 779 - 779
Tumor necrosis factor receptor superfamily member 4 (TNFRSF4; OX40: CD134) BriefCommunication Pages: 786 - 786
Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) (PPBP; CTAPIII) BriefCommunication Pages: 788 - 788
Apolipoprotein E (APOE); DNA-damage-inducible transcript 3 (DDIT3; CHOP10; CHOP; GADD153); low-density lipoprotein receptor (LDLR) BriefCommunication Pages: 789 - 789
Phosphodiesterase 4D, cAMP-specific (PDE4D); SNP rs1588265; SNP rs1544791 BriefCommunication Pages: 796 - 796
Disrupted in schizophrenia 1 (DISC1); glycogen synthase kinase 3β (GSK3B) BriefCommunication Pages: 801 - 801
Potassium voltage-gated channel, subfamily H (eag-related), member 2 (KCNH2) BriefCommunication Pages: 804 - 804
Reticulon 4 receptor (RTN4R; NgR; NgR1); reticulon 4 receptor–like 2 (RTN4RL2; NgR2); myelin-associated glycoprotein (MAG) BriefCommunication Pages: 805 - 805
Mitogen-activated protein kinase–activated protein kinase 2 (MAPKAPK2; MK2) BriefCommunication Pages: 808 - 808
Chromosomal instability gene signature to predict taxane resistance BriefCommunication Pages: 810 - 810
MicroRNA-145 to control human embryonic stem cell (hESC) pluripotency and differentiation BriefCommunication Pages: 813 - 813
